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The human growth hormone/chorionic somatomammotropin
(hGH/CSH) gene family is located at chromosome 17q22-24. It is
comprised of a pituitary growth hormone (GH1), a gene for placental
growth hormone (GH2), two chorionic somatomammotropin genes
(CSH1 and CSH2) and a chorionic somatomammotropin-like gene
(CSHL1; [1]). This gene family is thought to have arisen through three
successive duplications. An initial duplication gave rise to a pre-GH
and a pre-CSH gene. These two genes were then duplicated to give
rise to the GH1, CSH1, GH2 and CSH2 genes. Finally, a CSH1
duplication gave rise to CSHL1[1,2]. Since six genes are present in
chimpanzee and rhesusmonkey, six genes were likely present before
the divergence of Hominidae (the great apes, including human and
chimpanzee) and Cercopithecidae, some 30 million years ago and
the human lineage lost one [2–5]. Given the age of these genes, one
would expect that their nucleotide sequences would be quite
different from one another. However, all ﬁve human growth
hormone genes, and their ﬂanking regions, share from 91 to 99%
nucleotide identity [1]. Previous studies have shown that this
unexpectedly high degree of sequence similarity is in large part
due to gene conversions between these genes (see below).
The number of growth hormone sequences also varies in other
primate species. For example, the spider monkey has six growth
hormone genes whereas the marmoset has eight [3,4,6]. Furthermore,whereas the genomes of higher primates (simians) contain multiple
growth hormone genes, those of prosimians (e.g., the bush baby and
the slow loris) have a single growth hormone gene [6–8]. The
duplications of higher primate growth hormone genes therefore
occurred after the separation of the higher primate lineage from the
prosimian lineage [8–10].
Gene conversions are unidirectional recombination events where
genetic information is transferred from a donor gene to an acceptor
gene [11]. They often result in the loss of genetic information and in an
increase in homogeneity which contributes to maintain sequence
similarity and function between duplicated genes [11]. Detrimental
phenotypes can also arise through conversion events where harmful
mutations from other sequences are substituted into functional
duplicates [11,12].
In this context, studying gene conversion between human growth
hormone genes is particularly interesting because these different
genes are expressed in different tissues and are believed to have
different functions. One can therefore hypothesize that conversions
between them could change their functions, expression or both. The
GH1 gene codes for the main adult growth hormone and is primarily
produced in the somatotrophic cells found in the anterior part of the
pituitary gland. In contrast, the GH2, CSH1, CSH2 and CSHL1 genes are
mainly produced in placental tissue [1,13,14]. These ﬁve genes have
also shown to be expressed in a wide variety of tissues including
reproductive tissues and the retina [15,16]. Furthermore, these 5
different genes have different levels of sequence similarity. For
example, while the CSH1 and CSH2 genes code for polypeptides that
differ by a single amino acid, they both have 32 amino acid differences
with that coded by the GH1 gene (results not shown). Gene
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expression patterns or function.
The human growth hormone gene family has been the subject of
numerous evolutionary studies, many of which documented the
presence of gene conversions between the growth hormone genes of
humans and other primates [1–4,9,10,17–19]. However, many of
these studies focused on gene conversions in the promoter regions
and none of them have assessed the characteristics and impact of gene
conversions in all currently known primate growth hormone
sequences. Here, we present an extensive characterization of the
gene conversions that occurred between the growth hormone genes
of primates. We also hypothesized that since the GH1 gene codes for
the main adult growth hormone in humans, chimpanzee and rhesus
monkey (this gene is also called the GHN gene in chimpanzee and
rhesus monkey) that, due to selective pressures to preserve its
function, this genewill always act as a donor in conversion events, and
never as an acceptor. Our results show that gene conversions aremore
frequent between Hominidae genes than those of other primate
species. They also occur less frequently in more conserved gene
regions and towards the more functionally important GH1 gene.2. Materials and methods
The human growth hormone sequences, and those of 12 other
primate species, were obtained from NCBI (http://www.ncbi.nlm.
nih.gov/). The complete list of the GenBank accession numbers of the
56 growth hormone genes analyzed here are listed in Supplementary
Table 1. All the genes studied are made up of ﬁve exons and four
introns. Furthermore, all intron and exon lengths among these
sequences are similar (Fig. 1 and results not shown). In all cases, the
sequences used started with the ATG initiation codon and ended
with the stop codon.
Sequences were manipulated using BioEdit [20]. Alignments were
performed using ClustalW [21] and PRANK (http://www.ebi.ac.uk/
goldman-srv/webPRANK/). Phylogenetic trees were constructed with
the neighbor joining method implemented in MEGA 4 [22]. Default
parameters were used: Kimura's two parameter model, maximum
composite likelihood with 1st, 2nd, 3rd and non-coding codon
positions and 1000 replications for bootstrap analyses. The averageFig. 1. Graphical representation of the distribution of the 48 gene conversions detected betw
genes in all species examined. Whereas the 5 exons of these genes have the same length in al
indicated. The lines shown in the bottom part represent the approximate area covered by ea
order in which these conversions are shown corresponds to the order in which they are lisamount of sequence differences between all growth hormone genes of
each species was also calculated using MEGA 4 using the p-distance
model (i.e., the proportion of different nucleotides without any
correction for multiple substitutions) and the standard errors of these
average values were calculated using 500 bootstrap replicates.
The GENECONV 1.81 program (http://www.math.wustl.edu/
sawyer/geneconv/) implementing Sawyer's statistical method for
detecting gene conversion was used to identify gene conversion events
[23]. The accuracy of GENECONV has been previously tested and this
methodwas found to be a useful tool to detect gene conversions except
when the sequences analyzed are all very similar orwhen the sequences
comparedaremore than20%divergent [24–26]. If all sequences are very
similar, this method will fail to detect gene conversions (false negative
results) because therewill not be enough polymorphic sites to permute.
Conversely, this method gives false positive resultswhen the sequences
being compared aremore than20%divergent [25]. The growthhormone
genes of each specieswere analyzedusing amismatchpenalty of 2. Only
the global fragments with simulated P-values of less than 0.05 were
considered signiﬁcant. We did not consider pairwise fragments, even
when they had simulated P-values of less than 0.05, because these
fragments are not corrected for multiple comparisons.
The distribution of gene conversions along the sequences of
growth hormone genes was tested using a chi-square test. For each
species, the aligned sequences were divided into four regions of equal
length and the number of conversion events in each region was
counted. WebLogo (http://weblogo.berkeley.edu/) was used to assess
the degree of conservation of the amino acids along the sequence of
the growth hormone protein.3. Results
3.1. Gene conversions detected with GENECONV
Using GENECONV, gene conversions were detected between the
genomic copies of the growth hormone genes of all 11 species with
multiple growth hormone genes (the growth hormone gene is single
copy in the bush baby and slow loris genomes; Table 1). A total of 48
genomic conversions were detected with the smallest being 14
nucleotides long and the largest 1019 nucleotides long. The averageeen growth hormone genes. The top part represents the exon-intron structure of these
l species (black boxes labeled 1 to 5), the lengths of the introns show some variability, as
ch conversion, with each species having a different color code, as indicated. The species
ted in Table 1.
Table 1
Gene conversion events detected using GENECONV.
Species Sequences Length Location Sequences Length Location
Alouatta seniculus
(Howler monkey)
5(D);2(A) 273 Last 102 bp of exon 4 to ﬁrst 170 bp
of intron 4
5(D);2(A) 93 First 35 bp of exon 5 to last 76 bp
of exon 5
2(D);3(A) 651 Last 245 bp of intron 1 to last 105 bp
of exon 3
4(D);5(A) 38 First 126 bp of intron 1 to last 91 bp
of intron 1
1(?);5(?) 85 First bp of exon 1 to last 145 bp
of intron 1
2(D);4(A) 93 Last 86p of intron 2 to last 112 bp
of exon 3
3(D);4(A) 106 Last 55 bp of intron 3 to ﬁrst 50 bp
of intron 4
Hylobates leucogenys
(Northern white-cheeked gibbon)
5(D);4(A) 605 First bp of exon 1 to last 58 bp
of intron 2
7(?);1 (?)* 57 First 41 bp of intron 1 to ﬁrst 97 bp
of intron 1
4(D);7(A) 35 First 6 bp of exon 1 to ﬁrst 30 bp
of intron 1
Pithecia pithecia
(White-faced saki)
4(D);2(A) 239 Last 3 bp of exon 2 to ﬁrst 23 bp
of exon 3
1(?);3(?)* 29 First 8 bp of intron 2 to ﬁrst 36 bp
of intron 2
4(D);3(A)* 115 Last 55 bp of exon 4 to ﬁrst 59 bp
of intron 4
Rhinopithecus roxellana
(Golden snub-nosed monkey)
1(?);3(?) 41 First 47 bp of exon 2 to last 73
of exon 2
4(D);2(A) 223 First 8 of exon 2 to ﬁrst 70
intron 2
Callicebus moloch
(Red-bellied titi)
1(D);2(A) 44 Last 4 bp of exon 1 to ﬁrst 39 bp
of intron 1
1(D);3(A)* 103 Last 17 bp of exon 3 to last 7 bp
of intron 3
1(D);4(A)* 187 First 36 bp of exon 5 to last bp
of exon 5
3(D)*;2(A) 89 Last 56 bp of exon 4 to ﬁrst 32 bp
of intron 4
Macaca assamensis
(Assamese macaque)
2(D);1(A) 120 Last 49 bp of intron 1 to last 90 bp
of exon 2
Pygathrix nemaeus
(Red shanked douc langur)
3*(D);2(A) 379 Last 181 bp of intron 4 to last
bp of exon 5
3(?);5(?) 30 First 18 bp of exon 3 to ﬁrst 47 bp
of exon 3
3*(D);1(A) 54 First 47 bp of exon2 to ﬁrst 100
bp exon2
4(D);2(A) 1019 First bp of exon1 to last bp of exon 4
3(?);4(?) 42 First 89 bp of exon 4 to ﬁrst 130
of exon 4
Ateles geoffroyi
(Black-handed spider monkey)
GHV(?);GHC(?) 14 First 160 bp of intron 1 to last 79
bp of intron 1
Macaca mulatta
(Rhesus monkey)
CSH1(D);GH1(A) 87 First 140 bp of intron 1 to last 34
bp of intron 1
GH1(D);CSH3(A) 56 First 28 bp of exon 3 to ﬁrst 83 bp
of exon 3
CSH2(D);CSH4(A) 93 First 12 bp of exon 2 to ﬁrst 104
of exon 2
CSH3(D);CSH2(A) 23 Last 32 bp of intron 1 to last 10 bp
of intron 1
GH2(D);GH1(A) 165 First 186 bp of intron 2 to ﬁrst 22
bp of intron 3
CSH2(D);GH1(A) 25 First 31 bp of intron 1 to ﬁst 55 bp
of intron 1
CSH3(D);CSH4(A) 67 First 106 of exon 4 to ﬁrst 8 bp
of intron 4
GH2(D);CSH4(A) 22 First 23 bp of exon 3 to last 75 bp
of exon 3
GH1(?);GH2(?) 42 First 48 bp of exon 2 to ﬁrst 89
bp of exon 2
Pan troglodytes
(Chimpanzee)
GH1(D);PL-C(A) 368 First bp exon 1 to last 78 bp
of exon 2
PL-B(D);PL-A(A) 293 Last 43 bp of exon 3 to last bp of exon 4
GH2(D); PL-A(A) 293 First 16 bp of intron 2 to last 36
bp of exon 3
PL-C(D);PL-A(A) 67 First 34 bp of intron 1 to last 166 bp of
intron 1
PL-D(D);PL-A(A) 638 Last 40 bp of exon 3 to last 11
bp exon 5
GH1(D);PL-A(A) 73 Last 94 bp of exon 3 to last 22 bp
of exon 3
PL-D(D);PL-C(A) 675 Last 81 bp of exon2 to last 15 bp
of exon 4
GH2(D);PL-A(A) 68 First 15 bp of exon 2 to ﬁrst 82 bp
of exon 2
PL-C(D);PL-B(A) 590 First 25 bp of intron 2 to ﬁrst 12
bp of intron 4
GH1(D);GH2(A) 114 First 15 bp of exon 2 to last 32 bp
of exon2
PL-C(D);PL-A(A) 248 First 2 bp of intron 3 to last 9 bp
exon 4
Human CSH2(D);CSH1(A) 701 Last 76 bp exon 2 to last 26 bp
exon 4
CSHL1(D);CSH2(A) 148 Last 11 bp of exon 2 to ﬁrst 136 bp
of intron 2
Notes. (A) and (D) indicate acceptor and donor sequences respectively. Interrogation points (?) indicate conversions for which the polarity could not be determined. Asterisks (*)
indicate sequences that are likely pseudogenes.
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nucleotides. Although this average size does not take into account the
variation found in each gene and in different individuals of each species
(i.e., it is based on reference sequences obtained from NCBI), this
average size is similar to the mean length of 55 to 290 bp measured
using sperm analyses [27]. There are 8 conversions limited to intron
sequences and their average size is 42.5±25.3 nucleotides long. There
are 13 conversions limited to exon sequences and their average size is
70.6±42.5 nucleotides long. The average size of conversions limited to
intron sequences and those limited to exon sequences are not
statistically different (t-test, p=0.07). In contrast, the average size of
the 27 conversions spanning both introns and exons are 309.8±260.4nucleotides long and are signiﬁcantly longer than both the size of the
conversions limited to introns or the conversions limited to exons
(t- tests, p=0.00001 and p=0.00007, respectively).
The lengths of the converted regions are correlated with the
degree of similarity of the genes betweenwhich they occur. A positive
correlation exists between the lengths of converted regions identiﬁed
by GENECONV (Table 1) and the percent similarity of the sequences
found 100 bp before and after each converted region (r=0.46,
p=0.0009).
Converted regions are also more GC-rich than non-converted
regions. When considering the 23 conversions longer than 100 bp
identiﬁed byGENECONV(Table 1), the averageGC-content (±standard
Fig. 2. Phylogeny of the chimpanzee, macaque and human growth hormone genes. The scale bar represents 1% sequence divergence and the numbers at the nodes are the percent
bootstrap support.
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than the non-converted ones (55.44%±0.27; t- test, p=0.004). For this
analysis, only conversions larger than 100 bp were considered to
minimize the effect of stochastic variation.
For 40 of these 48 conversions, the origin of the converted
sequences was determined based on the patterns of nucleotide
variation outside the converted regions and the phylogenetic position
of the relevant sequences (Figs. 2 and 3). The polarity of the other
eight conversions could not be established due to the lack of sequence
information (these conversions are 85 nucleotides long or shorter)
resulting in either direction being equally likely. In the howler
monkey genes, one of the three species where ﬁve or more
conversions were detected, there is no evidence of a bias in the
direction of the conversions. For example, gene 2 of the howler
monkey is twice a donor and twice an acceptor and gene 4 is once a
donor and once an acceptor. Similarly, the chimpanzee PL-C gene is
three times a donor and twice an acceptor. However, the situation is
different for the chimpanzee PL-A gene that accepted seven
conversions and never converted any other gene. Moreover, in the
chimpanzee, the GH1 gene was three times a donor, and the GH2 and
PL-D genes were both twice donors, without any of these three genes
ever accepting a conversion. In the rhesus monkey, the GH2 gene was
twice a donor and never an acceptor.
Surprisingly, the results shown in Table 1 seem to suggest that
gene conversions are relatively rare in the human genome. In fact,
our GENCONV analyses detected only two gene conversions
between human genes compared with as many as eleven conversion
events between chimpanzee genes (Table 1). However, the
phylogenetic and sequence similarity analyses we present below
demonstrate that gene conversions are indeed frequent between
human growth hormone genes.
3.2. Phylogenetic analyses
Phylogenetic trees can be used to detect gene conversion events
because conversions between paralogous genes will often cause themto group together rather thanwith their orthologous genemembers in
other related species [24,28]. We therefore built phylogenetic trees to
complement our GENECONV results. Since our GENECONV results
clearly indicate that introns contain many converted regions, these
trees were built using genomic sequences.
Fig. 2 shows the phylogenetic tree for the three primate species for
which the complete growth hormone gene locus (and genome) has
been sequenced. This tree contains two main groups, one composed
uniquely of rhesus monkey sequences and one composed of human
and chimpanzee sequences. Such a topology would not be expected
if no gene conversions were present. Without gene conversions,
the orthologous genes of each species (e.g., the GH1 gene) should
be grouped together [i.e., (human GH1, chimpanzee GH1), rhesus
monkeyGH1)]. The fact that all rhesusmonkey sequences are grouped
together and separated by long branches is likely the result of the fact
that the gene conversions found in the rhesus monkey genome are
few and short whereas those in the human and chimpanzee genomes
are numerous and longer (Table 1), hence the clustering of human
and chimpanzee genes. The phylogenetic effects of conversions are
particularly evident between the human CSH1 and CSH2 where these
two paralogous genes are grouped together with a 91% bootstrap
value, rather than with their orthologous genes from chimpanzee or
rhesus monkey. The strongly supported grouping of these two human
genes is likely the result of the 701 nucleotide long gene conversion
between them (Table 1). Furthermore, the direction of the conversion
was most likely from the human CSH1 gene to the human CHS2 gene
because both these genes are a sister group to the chimpanzee PL-D
gene. This tree also shows that a gene conversion occurred between
the GH1 and GH2 genes in the common ancestor of human and
chimpanzee. This explains why these two paralogous genes are
grouped together while each still retains its human and chimpanzee
orthologous relationship.
The shorter branch lengths connecting the human and chimpanzee
sequences, compared with those connecting rhesus monkey sequences,
suggest that gene conversions have a stronger homogenization effects
betweenHominidae sequences thanbetweenCercopithecidae sequences
Fig. 3. Phylogeny of the growth hormone genes of all 13 primate species. The scale bar
represents 5% sequence divergence and the numbers at the nodes are the percent
bootstrap support. Stars (*) indicate sequences which are likely pseudogenes.
Table 2
Average similarities of the growth hormone genes found in the genome of primate
species.
Species Complete deletion Pairwise deletion
Mean±s. e. Mean±s. e.
Alouatta seniculus (Howler monkey) 0.120±0.006 0.120±0.005
Hylobates leucogenys
(Northern white-cheeked gibbon)
0.068±0.005 0.070±0.005
Pithecia pithecia (White-faced saki) 0.138±0.006 0.139±0.006
Rhinopithecus roxellana
(Golden snub-nosed monkey)
0.069±0.005 0.070±0.005
Callicebus moloch (Red-bellied titi) 0.129±0.006 0.129±0.005
Macaca assamensis (Assamese macaque) 0.098±0.005 0.098±0.005
Pygathrix nemaeus
(Red shanked douc langur)
0.138±0.006 0.139±0.005
Ateles geoffroyi
(Black-handed spider monkey)
0.135±0.007 0.134±0.008
Macaca mulatta (Rhesus monkey) 0.098±0.005 0.098±0.005
Pan troglodytes (Chimpanzee) 0.060±0.004 0.060±0.005
Homo sapiens (Human) 0.060±0.004 0.061±0.004
Notes. Complete deletion refers to average similarities calculated with all gaps deleted
from all sequences. Pairwise deletion refers to average similarities calculated with gaps
deleted only from the pairs of sequences being compared. s.e., standard error.
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nucleotide differences between all the growth hormone genes found in
the genomes of all 11 species having multiple growth hormone gene
sequences (Table 2). These results, whether alignment gaps found in onesequence are removed from all sequences or only between pairs of
sequences, show that human and chimpanzee (Hominidae) gene
sequences are, on average, more similar to one another than those of
any other primate species.
Fig. 3 shows the phylogenetic tree for the sequences of all primate
species for which growth hormone genomic sequences are available.
Although some groups most likely represent groups of orthologous
genes, such as the black-handed spider monkey GHN and howler
monkey 1 sequences, most do not. Here again, the numerous gene
conversions have obscured the relationships of the different genes.
For example, it is impossible to determine which gene in other species
is orthologous to genes 1, 4, 5 and 6 from the northern white-cheeked
gibbon because these four genes form a strongly supported group
whose sister group is a mixture of human and chimpanzee genes.
Furthermore, perhaps excluding gene 1 of the golden snub-nosed
monkey, this tree cannot be used to establish which gene from the
other 10 primate species with multiple growth hormone genes is
likely orthologous to the rhesus monkey GH1 gene.
The relationships between the human and chimpanzee sequences
previously found in Fig. 2 are also observed in Fig. 3, providing further
evidence for frequent gene conversion in their common ancestor. This
tree also provides strong evidence for three gene conversions which
had not been detected using the GENECONVmethod. Genes 4 and 5 of
the assamese macaque, genes 1 and 6 of the northern white-cheeked
gibbon and genes 2 and 3 of the northern white-cheeked gibbon form
three strongly supported pairs of genes which suggest that they are
evolving in concert due to frequent gene conversions (Fig. 3). The fact
that the GENECONVmethod did not detect these conversions is due to
the high degree of similarity of these genes over their whole length.
For example, genes 4 and 5 of the assamesemacaque are 97.6% similar
at the nucleotide level (results not shown). The high degree of
sequence similarity of these three pairs of genes is also represented by
the short length of the branches between the members of each pair
(Fig. 3). Using the scale bar of this ﬁgure, one can measure that each
pair has less than 5% differences at the nucleotide level (including
exons and introns).
3.3. Number of gene conversions in different species
The number of gene conversions detected in the 11 species having
multiple growth hormone genes is highly variable (Table 1). Whereas
a single gene conversion was detected in the genomes of the
Assamese macaque and the black-handed spider monkey, 11 were
Fig. 4. LOGO representation of the degree of amino acid conservation along the 48 primate growth hormone protein sequences. The height of each letter is proportional to the degree
of conservation of each amino acid (in one letter code). Numbers below each amino acid represent their position in the growth hormone sequence.
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correlation between the number of growth hormone genes in a
species and the number of conversions found in that species
(r2=0.25), this correlation is not signiﬁcant (p=0.14). This suggests
that the number of conversion is not proportional to the number of
genes present in a genome.
3.4. Distribution of gene conversions in growth hormone genes
The distribution of gene conversions was analyzed in order to
determinewhether gene conversions occurwith equal frequency in the
different regions of growth hormone genes. Since visual inspection of
the distribution of gene conversions (Fig. 1) suggests that gene
conversions are less frequent in the last quarter of these sequences,
the genes of each species were divided into four regions of equal length.
The number of conversions that occurred in each region was tested
using a chi-square test. Note that if a conversion spanned two or three
gene regions it was counted as having occurred in all of them. This test
shows that gene conversions are not evenly distributed throughout
growthhormone genes.With 20, 19, 16 and 6 conversions in each of the
consecutive regions, there are signiﬁcantlymore conversions in the ﬁrst
three-quarters of the gene than in the last quarter of the gene
(p=0.045). Interestingly, this uneven distribution reﬂects the uneven
distribution of conserved amino acids along the sequences of growth
hormone sequences where amino acids from 140 to 217 are more
conserved than those found in positions 1 to 139 (Fig. 4).4. Discussion
Although several studies previously addressed the impact of gene
conversions on the evolution of growth hormone genes, our study is
the ﬁrst to present comprehensive analyses of primate growth
hormone genes using genomic sequences of the coding regions.
Several previous studies analyzed haplotypes and focused on the
occurrence and effects of gene conversion events in the promoter
regions of human genes [2,14,17–19]. These studies showed that gene
conversions are frequent in the promoter regions of growth hormone
genes and that the direction of the gene conversions are often from
the four placental genes towards the promoter region of the GH1 gene.
Our results are consistent with previous studies. The long gene
conversion that we detected between the human CSH1 and CSH2
genes has been observed by at least three previous studies (Table 1;
references [1,18,29]). Similarly, in the chimpanzee genome, the 368
nucleotide long conversion between the PL-C and GH1 (GHN) genes
we detected, and the 293 nucleotide long conversion between the PL-
A and GH2 (GHV) genes, were also detected by Revol deMendoza et al.
[3] simply on the basis of the unexpectedly high amino acid sequence
similarity they observed in these regions. However, these authors did
not detect the other 9 conversions we detected in this genome
(Table 1). Li et al. [9] analyzed the genomic sequences of the howler
monkey, the red-bellied titi and the white-faced saki growth hormone
genes and found 4, 3 and 1 conversions in these species, respectively.
Even though we found more conversions than them, our results, i.e.,
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prior studies. Any differences are likely due to the fact that they used a
variety of mismatch penalties (scale values) when they ran GENE-
CONV and that they reported the longest estimates they obtained
from several analyses. In contrast, the fact that the GENECONV
analysis of the 6 rhesus monkey growth hormone genes performed by
Gonzáles Alvarez et al. [4] revealed only three gene conversions,
compared with our 10 (Table 1), is due to the fact that they did not
allow for anymismatches within converted regions. Finally, we do not
know why Ye et al. [10] detected only 3 gene conversions among the
21 growth hormone gene sequences they analyzed. However, we
suspect it is because they performed a single GENECONV analysis on
all 21 aligned sequences from diverse primate species rather than
performing separate GENECONV analyses for each species. This
stresses the fact that consistent and appropriate analysis criteria
have to be used to perform in depth comparative genomic analyses.
One implication of the high frequency of gene conversion events
between growth hormone genes is that it makes it pointless to try to
establish the orthologous relationships between genes in different
primate species. For example, given that the chimpanzee and rhesus
monkey genomes both have 6 growth hormone genes, one would
expect that these twelve genes could be grouped into 6 pairs of
orthologous genes. However, as demonstrated by the phylogenies
shown in Figs. 2 and 3, deﬁning such groups is impossible. In fact, even if
the precise chromosomal gene order was known for both species, one
could not claim that speciﬁc genes are orthologous based on their
chromosomal location because, although the locations are conserved,
the sequence of each gene no longer reﬂects their common ancestry but
is simply the result of the diverse conversion events that affected each
gene. The variable number of genes and the repeated conversions that
occurred between them therefore make it impossible to infer the order
of duplication or lost eventswhichwere responsible for the evolution of
these genes in each species.
The fact that the conversions limited to intron and exon sequences
are signiﬁcantly smaller than those spanning both exons and introns
is likely due to different factors. Since the lengths of conversions are
inversely correlated with the amount of sequence similarity between
the donor and acceptor sequences, the lengths of conversion tracts
between non-coding sequences are expected to be shorter because
non-coding regions evolve faster than coding regions and are
therefore more dissimilar [30–34]. In contrast, the small lengths of
conversions limited to (more similar) exon sequences likely reﬂects
the action of purifying selection eliminating longer conversions
affecting essential amino acids. Therefore, the fact that the conver-
sions spanning both exons and introns are signiﬁcantly larger than
those limited to introns or exon sequences likely represents
conversions that occurred in regions under little selective pressures.
This interpretation is consistent with the fact that in the rhesus
monkey the three conversions where GH1 (coding for the main adult
growth hormone) was the acceptor gene are all limited to intron
sequences (Table 1). Furthermore, it is also consistent with the fact
that among the conversions we detected between chimpanzee
growth hormone genes, the GH1 gene was never an acceptor
sequence. Therefore, our results are in agreement with those of
previous studies that found that gene conversions affecting functional
sites are selected against [35–37].
The signiﬁcant correlation (p=0.0009) between the length of the
conversions and the degree of similarity of the regions ﬂanking these
conversions is consistent with previous studies in bacterial, yeast and
mammalian genes [30–34]. Longer conversions therefore tend to
occur between more similar genes. As discussed further below, this is
particularly relevant to the evolution of Hominidae growth hormone
genes because their overall higher average sequence similarities
(Table 2) are responsible for their higher degree of homogenization.
In other words, there is a positive feedback loop between gene
conversion frequency and sequence similarity. The high degree ofsimilarity between these sequences allows them to convert one
another frequently. In turn, these frequent conversions lead to higher
similarity, and so on.
These frequent conversions not only lead to higher sequence
similarity, but also to higher GC-content. The fact that the average GC-
content of converted regions is signiﬁcantly higher (p=0.004) than
those of non-converted regions is consistent with the biased gene
conversion hypothesis which posits that, due to biases in DNA repair
mechanisms, higher gene conversions frequencies will lead to higher
GC-content [38]. This observation demonstrates that gene conversions
are so frequent between the growth hormone genes of primates that
they affect their GC-content.
The lack of signiﬁcant correlation between the number of
conversions observed in a species and the number of genes present
in its genome suggest that the number of genes has no inﬂuence on
the frequency of gene conversion events. This is in contrast with the
situation in bacterial genomes where the number of conversions is
correlated with the size of the gene families, a result which likely
reﬂects more frequent conversion events as the number of potential
conversion partner increases [39]. However, our conclusion assumes
that all gene conversions were detected. Since the phylogenetic
analyses presented above demonstrate that the GENECONV method
did not detect all gene conversions present in some genomes, this
conclusion is only tentative. Similarly, the fact that we cannot
accurately calculate the number of gene conversions that occurred
between the human genes, and that we do not know the genomic
gene arrangement of the species other than those of rhesus-monkey,
chimpanzee and human, precludes us from assessing whether the
proximity of the duplicated genes affects the number of gene
conversions observed [40].
The fact that the GENECONV method failed to detect all gene
conversions in all genomes is the result of the high similarity of the
genes found in these genomes [24–26]. Since this method assesses
whether the nucleotide differences found between two sequences
are randomly distributed along the length of these sequences, it
cannot detect if a given region has less differences than its ﬂanking
regions if the two sequences are almost identical over their whole
length. This stresses the fact that other methods, such as phyloge-
netic trees, have to be used to identify gene conversions spanning the
whole length of genes [24]. Phylogenetic trees are particularly useful
in this respect because they not only show the topological clustering
of converted genes but also provide a visual representation of the
degree of similarity between these sequences. Their main drawback
is that they cannot easily be used to deﬁne the location of converted
regions [24].
Previous studies have shown that conversion between genomic
and cDNA copies lead to an excess of conversions in the 3′-end of
genes [41–43]. The fact that gene conversions are less abundant at the
3′-end of growth hormone genes suggests that most conversion
events observed in this gene family occur between genomic copies
and not between genomic copies and their cDNA molecules (Fig. 1).
Moreover, the fact that the uneven distribution of converted regions
reﬂects the uneven distribution of conserved amino acids along the
sequences of growth hormone sequences suggests that the carboxy-
end of growth hormone proteins are under higher selective
constraints compared to those in their amino-terminal and central
regions (Fig. 4). This biased distribution of conserved amino acids
towards the carboxy-end of the growth hormone protein has
previously been documented [44]. These authors showed that 13 of
the 33 amino acids conserved in 21 vertebrate species are located in
the last 31 amino acids of the growth hormone protein. This part of
the protein constitutes a conserved domain, called the GD5 domain,
and is likely involved in the formation and stabilization of these
proteins [44]. X-ray crystallography has shown that the carboxy-end
of the growth hormone protein is found buried in the growth
hormone and prolactin receptors with which it interacts [45]. This
180 N. Petronella, G. Drouin / Genomics 98 (2011) 173–181protein region also includes three residues (Arg 167, Asp 171 and Glu
174, following the numbering of the human growth hormone), which
are critical to bind and distinguish between these two receptors [45].
Therefore, the signiﬁcantly lower frequency of gene conversion at the
3′-end of primate growth hormone genes is likely the result of
stronger purifying selection at the carboxy-end of growth hormone
proteins (Table 1, Figs. 1 and 4). This is consistent with other studies
which have shown that functionally important regions are immune to
gene conversions [35–37].
Our results concerning the directions of gene conversions are also
consistent with the suggestion that the biased directionality we
observed is the results of purifying selection. This is supported by the
fact that gene conversion biases are not observed in most of the
species we studied. However, in the few instances where gene
conversion biases are present, these biases are always from the most
functionally important gene (i.e., the GH1 and GH2 genes) to genes of
lesser functional importance (e.g., the human CSH genes; Table 1). As
mentioned above, the GH1 gene (also called the GHN gene in
chimpanzee and rhesus monkey) codes for the main adult growth
hormone and is primarily transcribed in the pituitary gland. In
contrast, the GH2, CSH1, CSH2 and CSHL1 genes are mainly
transcribed in placental tissue [1,13–16]. The higher functional
importance of the human GH1 gene, relative to the four other growth
hormone genes, is reﬂected by the fact that most growth hormone
deﬁciency cases are due to mutations (mainly deletions) in the GH1
gene and never in the three CSH growth hormone genes [46,47]. This
is consistent with the existence of a single growth hormone gene in
prosimians and most mammals and the fact that there is a single
worldwide GH1 variant in human populations [9,10,18]. It is also
consistent with the fact that no clinical disorders are observed when
CSH genes are deleted or when their corresponding hormones are
missing [18]. Finally, the few cases where growth hormone
deﬁciencies have been observed in the presence of an intact GH1
gene are believed to be due tomutations in cis-acting GH1 regulatory
sequences [46,48]. The biased gene conversion direction observed
for the GH2 gene of chimpanzee and rhesus monkey, where this gene
always acts as a donor and never as an acceptor, also suggests that
conversion towards this gene are selected against. Although GH2
likely does not have a direct effect on fetal growth, because it is not
detectable in the fetal circulation, it is believed to be involved in
driving normal fetal growth [49,50]. This suggests that deleterious
conversions in functionally important genes are being eliminated by
natural selection whereas neutral conversions are not. This is
consistent with the suggestion that the high frequency of gene
conversions in the promoter region of the GH1 gene reﬂects relaxed
selective constraints in that region [2,18].
In conclusion, our results show that gene conversions occurred
between the growth hormone genes of all 11 primates we analyzed
but that they had a stronger homogenizing effect between the
Hominidae genes than between those of other primate species. The
fact that conversions are less frequent in conserved gene regions, and
towards functionally important genes, suggests that detrimental
conversion events are being eliminated by purifying selection.
Therefore, the high degree of sequence similarity observed between
the growth hormone genes of primate species is a consequence of
frequent gene conversions in gene regions which are under little
selective constraints.
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